Literature DB >> 11159886

Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury.

A Nakajima1, K Wada, H Miki, N Kubota, N Nakajima, Y Terauchi, S Ohnishi, L J Saubermann, T Kadowaki, R S Blumberg, R Nagai, N Matsuhashi.   

Abstract

BACKGROUND & AIMS: Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor whose activation has been linked to several physiologic pathways including those related to the regulation of intestinal inflammation. We sought to determine whether PPAR gamma could function as an endogenous anti-inflammatory pathway in a murine model of intestinal ischemia-reperfusion (I/R) injury.
METHODS: PPAR gamma-deficient and wild-type mice were examined for their response to I/R procedure. Treatment with a PPAR gamma-specific ligand was also performed.
RESULTS: In a murine model of intestinal I/R injury, we observed more severe injury in PPAR gamma-deficient mice and protection against local and remote tissue injury in mice treated with a PPAR gamma-activating ligand, BRL-49653. Activation of PPAR gamma resulted in down-regulation of intercellular adhesion molecule 1 expression by intestinal endothelium and tissue tumor necrosis factor alpha messenger RNA levels most likely by inhibition of the NF-kappa B pathway.
CONCLUSIONS: These data strongly suggest that an endogenous PPAR gamma pathway exists in tissues that may be amenable to therapeutic manipulation in I/R-related injuries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159886     DOI: 10.1053/gast.2001.21191

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  59 in total

Review 1.  Involvement of PPAR nuclear receptors in tissue injury and wound repair.

Authors:  Liliane Michalik; Walter Wahli
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 2.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

Review 3.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

4.  Glutamine activates peroxisome proliferator-activated receptor-γ in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism.

Authors:  Kechen Ban; Julie M Sprunt; Stephanie Martin; Peiying Yang; Rosemary A Kozar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-07       Impact factor: 4.052

5.  Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.

Authors:  Francesco Perri; Giuseppe Di Lorenzo; Giuseppina Della Vittoria Scarpati; Carlo Buonerba
Journal:  World J Clin Oncol       Date:  2011-03-10

6.  Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Authors:  Salvatore Cuzzocrea; Barbara Pisano; Laura Dugo; Angela Ianaro; Nimesh S A Patel; Rosanna Di Paola; Tiziana Genovese; Prabal K Chatterjee; Massimo Di Rosa; Achille P Caputi; Christoph Thiemermann
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

7.  Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats.

Authors:  Emma Folch-Puy; Susana Granell; Juan L Iovanna; Marc Barthet; Daniel Closa
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

8.  Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice.

Authors:  Atsushi Nakajima; Koichiro Wada; Kazufumi Katayama; Lawrence Saubermann; Emi Osawa; Hajime Nagase; Norio Ueno; Nobuyuki Matsuhashi; Hiroyuki Aburatani
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

9.  Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure.

Authors:  C Thiemermann
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

10.  Gastrointestinal Cytoprotection by PPARγ Ligands.

Authors:  Yuji Naito; Tomohisa Takagi; Toshikazu Yoshikawa
Journal:  PPAR Res       Date:  2010-09-21       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.